Boston Startup Funding Hits Four-Year High but Lags Behind AI Boom

Boston-area startups have raised about $7.8 billion in venture funding so far this year, the highest total in four years. But the gains tell a story of modest recovery, not a boom. Across the U.S., venture capital has surged to unprecedented levels, driven almost entirely by artificial intelligence.

A Tale of Two Funding Climates

The national VC picture is dominated by AI. In the first quarter of 2026, North America venture funding hit a record $252 billion. More than 87% of that went to companies in AI-related categories. Many of the biggest rounds went to San Francisco Bay Area firms such as OpenAI and Anthropic. Boston landed none of those mega-fundraisers.

The region's traditional strength in biotech has not delivered comparable scale. While biotech funding remains steady, no single round can compete with the $122 billion that OpenAI raised in one go. This disparity has sparked concern among local investors and founders.

Why This Matters

For Boston's startup ecosystem, the risk is not a funding freeze but a loss of relevance. The city has long been a top destination for venture capital behind Silicon Valley. But if AI investment continues to concentrate in the Bay Area, Boston could see its share of national VC shrink. That would affect not just startups but the broader innovation economy, including jobs, research and university partnerships.

Still, Large Rounds Emerge

Despite the AI gap, Boston has produced several large funding rounds this year. At least 12 companies in the metro area raised rounds of $200 million or more.

The largest was Whoop, a wearable fitness technology company that secured $575 million in Series G funding at a $10.1 billion valuation. Whoop uses AI models trained on billions of hours of physiological data.

Cloaked, a privacy and security startup, raised $375 million in Series B funding led by General Catalyst and Liberty City Ventures. Devoted Health, which provides Medicare plans, closed $366 million across two Series F tranches.

Other notable rounds include biotech and healthcare companies, areas where Boston has historically excelled. But the absence of a homegrown AI giant leaves the region watching from the sidelines as the biggest funding wave in history passes through California.